Avagenesis Corp. Receives ISO 13485 and 9001 for Bioprocessing and Cell Isolation System

September 3, 2015 3:01 PM

CALGARY, AB / ACCESSWIRE / September 3, 2015 / Avagenesis Corp. (TSXV: VVA) ("Avagenesis" or the "Company") is pleased to announce that its licensed bioprocessing and cell isolation system has received a Certificate of Registration for compliance with ISO 13485 and 9001 (the "ISO Certification"). ISO Certification demonstrates to customers that the Company's contracted commercially manufactured bioprocessing system to isolate stem cells...

Read more

Professor Robert Langer Advises Accurexa in the Development of its ACX-31 Program

September 3, 2015 8:46 AM

NEWARK, DE / ACCESSWIRE / September 3, 2015 / Accurexa Inc. (the "Company") (OTCQB: ACXA), a biotechnology company focused on the development of novel neurological therapies that can deliver therapeutics directly into the brain, announced today that Professor Robert Langer agreed to advise the Company in the development of its ACX-31 Program for the local delivery of temozolomide in combination with BCNU, both chemotherapeutics, in the treatment...

Read more

Vitro Biopharma Announces Advancement of its Traumatic Brain Injury Clinical Trial and a Favorable Ruling from the FDA

September 2, 2015 12:40 PM

GOLDEN, CO / ACCESSWIRE / September 2, 2015 / Vitro Diagnostics, Inc. (OTC: VODG), dba Vitro Biopharma, announced advances in clinical applications of its products and a favorable ruling by the FDA regarding this trial. The Company's phase I clinical trial consists of combining two previously FDA-approved drugs in a novel manner to treat TBI, including concussion, by regeneration of damaged cells through the activation of resident stem cells...

Read more

Accurexa to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

September 1, 2015 8:00 AM

NEWARK, DE / ACCESSWIRE / September 1, 2015 / Accurexa Inc. (the "Company") (OTCQB: ACXA), a biotechnology company focused on the development of novel neurological therapies that can deliver therapeutics directly into the brain, announced today that it will present at the 17th Annual Rodman & Renshaw Global Investment Conference taking place from September 8-10, 2015 at the St. Regis Hotel in New York City. George Yu, MD, President &...

Read more

Heliospectra Adds New LED Grow Lights to Horticulture Lamp Portfolio

August 27, 2015 8:00 AM

GÖTEBORG, SWEDEN and SAN FRANCISCO, CA / ACCESSWIRE / August 27, 2015 / Heliospectra AB (OTCQB:HLSPY, FIRSTNORTH: HELIO) is proud to announce the launch of two new lamp products, the E60 and the Heliospectra LightBar. Heliospectra, known for it's best-of-breed Light Recipe software, is positioned to accept pre-orders for the E60, a full spectrum, horticulture top-light designed for commercial growers. Built from the LX60 platform, the E60...

Read more

Heliospectra Featured in New Greenhouse and LED Grow Light Market Reports by Leading Research Firm

August 26, 2015 8:00 AM

GÖTEBORG, SWEDEN and SAN FRANCISCO, CA / ACCESSWIRE / August 26, 2015 / Heliospectra AB (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technologies for plant research and greenhouse cultivation, has been recognized in MarketandMarkets' new AgTech research reports, entitled "Smart Greenhouse Market - Forecast to 2020" and "LED Grow Light Market - Forecast to 2020". These reports analyze the market trends for each...

Read more

Heliospectra Completes $3 Million Private Placement

August 21, 2015 8:00 AM

GÖTEBORG, SWEDEN and SAN FRANCISCO, CA / ACCESSWIRE / August 21, 2015 / Heliospectra AB (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technologies for plant research and greenhouse cultivation, has completed a private placement of 2,500,000 shares at the issue price of SEK 10 per share. The directed new share issue provides the company with 25 million SEK (2.93 million USD) before transaction costs. The rights...

Read more

Hydromer, Inc. Announces the Release of Three (3) New Medical Ultra-Hydrophilic Coatings Specifically to Stay Wet (Hydrated) Longer for Urological, Gynecological and Gastrointestinal Catheters and Devices

August 19, 2015 4:02 PM

BRANCHBURG, NJ / ACCESSWIRE / August 19, 2015 / Hydromer, Inc. (PINKSHEETS: HYDI) announces the release of three (3) new Medical Ultra-Hydrophilic coatings specifically to "stay wet" (hydrated) longer for use Urological, Gynecological and Gastrointestinal catheters and devices. These specialty coatings will be marketed under the "STAYWET (TM)" brand. In particular, urological "Self-Catheters" also known as Nelaton or Intermittent Urinary...

Read more

DV Biologics Reports: Earth Science Tech Hemp CBD Oil Deters the Formation of Reactive Oxygen Species (ROS) on Human Brain Cells

August 18, 2015 8:00 AM

DV Biologics, a Leading Biological company, Reports Earth Science Tech (ETST) High Grade Hemp CBD (Cannabidiol) Oil Deters the Formation of Reactive Oxygen Species (ROS) on Human Brain Cells: May serve as a Neuroprotectant BOCA RATON, FL / ACCESSWIRE / August 18, 2015 / Earth Science Tech, Inc. ("ETST" or "the Company"), a unique biotechnology company focused on nutraceuticals, bioceuticals and dietary supplements, announced today that DV...

Read more

Entia Biosciences, Inc. Names Chief Executive Officer to Manage Growth of Consumer Health Products and To Launch New Medical Food Brands

August 13, 2015 9:54 AM

New Business Strategy to Capitalize on Unique, Innovative and Proprietary Entia Products SHERWOOD, OR / ACCESSWIRE / August 13, 2015 / Entia Biosciences, Inc. (OTCQB: ERGO), today announced that Carl J. Johnson has joined the Company to serve as its President and Chief Executive Officer and member of the Board of Directors. Mr. Johnson has more than 40 years of experience in managing the introduction and marketing of new health-related products...

Read more

Accurexa Licenses Combination of Local Temozolomide with Local BCNU Patent

August 12, 2015 8:00 AM

NEWARK, DE / ACCESSWIRE / August 12, 2015 / Accurexa Inc. (the "Company") (OTCQB: ACXA), a biotechnology company focused on developing and commercializing novel neurological therapies, announced today that it has entered into an exclusive license agreement ("ACL License") with Accelerating Combination Therapies LLC ("ACL") in regards to the exclusive licensing of the issued U.S. Patent No. 8,895,597 B2 Combination of Local Temozolomide with...

Read more

Theralase Appoints Experienced Sales and Marketing Team to Launch Next Generation Therapeutic Laser

July 17, 2015 9:52 AM

TORONTO, ON / ACCESSWIRE / July 17, 2015 / Theralase Technologies Inc. ("Theralase" or the "Company") (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and destroy cancer, announced today that it has appointed an experienced sales and marketing team to launch its next generation therapeutic laser. The TLC-2000 therapeutic laser with patented Cell Sensing(TM)...

Read more

Heliospectra AB Replaces All of Pinkhouse Bloom LLC's HID/HPS Cannabis Cultivation Lighting With Heliospectra LX601C LED Grow Lights

July 14, 2015 8:00 AM

Pinkhouse Blooms LLC., a leading cannabis cultivation and dispensary operation focused on high quality product development, strain diversity, energy efficiency and overall operational sustainability, has replaced all of their archaic lighting with Heliospectra's LED luminaires SAN FRANCISCO, CA / ACCESSWIRE / July 14, 2015 / Heliospectra AB (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technologies for plant...

Read more

Heliospectra AB to Exhibit and Present at the the MoneyShow in San Francisco, California

July 13, 2015 12:39 PM

SAN FRANCISCO, CA / ACCESSWIRE / July 13, 2015 / Heliospectra AB (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for plant research and greenhouse cultivation, will be speaking and exhibiting at the Money Show in San Francisco, CA. The Money Show will be held at the San Francisco Marriott Marquis from July 16 to July 18. Heliospectra will be exhibiting at Booth #415. Mr. Staffan Hillberg, CEO and co-founder...

Read more

Entia Biosciences CEO Dr. Hausman to Represent GROH(R) at Cosmoprof North America

July 9, 2015 2:13 PM

PORTLAND, OR / ACCESSWIRE / July 9, 2015 / Entia Biosciences, Inc. (OTCQB: ERGO), is excited to announce Dr. Marvin S. Hausman, MD and CEO will be representing the Company's GROH(R) Professional brand of hair and skin care products at Cosmoprof North America (CPNA), the largest international B2B beauty event in the Americas. Dr. Hausman and his team have created a revolutionary 'Smart Nutrient Technology' that combines natural formulations with...

Read more

Heliospectra AB to Exhibit at Cultivate'15 in Columbus, OH

July 3, 2015 6:00 PM

Heliospecta to Exhibit at Largest Horticulture Expo in North AmericaGÖTEBORG Sweden / SAN FRANCISCO, CA / ACCESSWIRE / JULY 3, 2015 / Heliospectra AB (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for plant research and greenhouse cultivation, will be exhibiting at Cultivate’15 in Columbus, OH. This year’s Cultivate will be held at the Greater Columbus Convention Centre from Jul 11 to...

Read more

Accurexa Appoints William Callahan to Its Board of Directors

July 2, 2015 8:00 AM

NEWARK, DE / ACCESSWIRE / July 2, 2015 / Accurexa Inc. (the "Company") (OTCQB: ACXA), a biotechnology company focused on developing and commercializing novel neurological therapies, announced today that William Callahan has been appointed to its Board of Directors, effective July 1, 2015. Mr. Callahan has spent most of his more than 30-year career in emerging growth companies in the medical device, drug delivery and pharmaceutical industry,...

Read more

Dixie Brands,Inc., Heliospectra AB & AmericanCannabis Engage in Three Party Cannabis Cultivation Alliance

June 30, 2015 8:00 AM

DENVER, CO and GÖTEBORG, SWEDEN / ACCESSWIRE / June 30, 2015 / Dixie Brands,Inc. (Dixie) the most trusted source for innovative, safe, effective and delicious cannabis products has tapped American Cannabis Company, Inc. (OTCQB: AMMJ), a full-service cannabis industry consultant and provider of proprietary and preferred products, for management of their new cultivation facility which will feature energy efficient lighting technology from...

Read more

Accurexa Announces Equity Financing of $2.25 Million

June 17, 2015 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / June 17, 2015 / Accurexa Inc. ("Accurexa" or the "Company"), (OTCQB: ACXA), a biotechnology company focused on developing and commercializing novel neurological therapies, today announced that it has entered into definitive agreements with institutional investors, led by a healthcare dedicated fund, for the private placement of 2,250 shares of the Company's convertible preferred stock for gross proceeds to the...

Read more

Heliospectra AB to Exhibit at the Cannabis World Congress & Business Expo in NYC

June 17, 2015 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / June 17, 2015 / Heliospectra AB (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for plant research and greenhouse cultivation, is pleased to announce that it will be exhibiting at the 2nd Annual Cannabis World Congress & Business Expo. The conference will be held at the Jacob Javits Center in New York, NY from Wednesday, June 17 through Friday, June 19. Heliospectra will...

Read more